ARGONAUT THERAPEUTICS LIMITED - OXFORD
Company Profile | Company Filings |
Overview
ARGONAUT THERAPEUTICS LIMITED is a Private Limited Company from OXFORD UNITED KINGDOM and has the status: Active.
ARGONAUT THERAPEUTICS LIMITED was incorporated 8 years ago on 08/02/2016 and has the registered number: 09993166. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 31/03/2025.
ARGONAUT THERAPEUTICS LIMITED was incorporated 8 years ago on 08/02/2016 and has the registered number: 09993166. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 31/03/2025.
ARGONAUT THERAPEUTICS LIMITED - OXFORD
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
30 / 6 | 30/06/2023 | 31/03/2025 |
Registered Office
MAGDALEN CENTRE ROBERT ROBINSON AVENUE
OXFORD
OX4 4GA
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
07/02/2023 | 21/02/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
DR NICHOLAS BARRIE LA THANGUE | Nov 1957 | British | Director | 2016-02-08 | CURRENT |
MR WILLIAM JOHN ROBERT FLEMING | Oct 1966 | British | Director | 2023-02-22 | CURRENT |
DR ANDREW MCLEAN | May 1985 | British | Director | 2016-04-14 UNTIL 2019-10-09 | RESIGNED |
MR KYING HA LEE | Aug 1963 | South Korean | Director | 2018-11-01 UNTIL 2021-01-22 | RESIGNED |
MR BUNGKWN LEE | Apr 1960 | South Korean | Director | 2018-12-21 UNTIL 2022-09-26 | RESIGNED |
DR SIMON KERRY | Jul 1963 | British | Director | 2017-08-09 UNTIL 2023-02-22 | RESIGNED |
MR NICHOLAS GEORGE DIXON-CLEGG | Nov 1989 | British | Director | 2020-08-01 UNTIL 2023-02-22 | RESIGNED |
DOUGLAS MCDONALD | Secretary | 2016-04-13 UNTIL 2022-12-22 | RESIGNED | ||
DR CHAN-HEE PARK | Oct 1969 | South Korean | Director | 2021-01-22 UNTIL 2022-12-22 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Ingenox Therapeutics Limited | 2022-12-22 | Oxford |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
Oxford Sciences Innovation Plc | 2016-04-06 - 2022-12-22 | Oxford |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
Prof Nicholas Barrie La Thangue | 2016-04-06 - 2018-09-27 | 11/1957 | Bridge Of Weir | Ownership of shares 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
ACCOUNTS - Final Accounts preparation | 2018-12-01 | 28-02-2018 | 381,868 Cash 336,667 equity |
ACCOUNTS - Final Accounts preparation | 2017-11-07 | 28-02-2017 | 164,301 Cash 117,528 equity |